Entering text into the input field will update the search result below

Aesthetic Medical International Holdings Group Limited (AIH) Q3 2022 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) Q3 2022 Results Conference Call November 29, 2022 7:00 AM ET

Company Participants

Derrick Shi - IR Associate Director

Pengwu Zhou - Chairman, CEO

Toby Wu - CFO


Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Aesthetic Medical International Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded.

On the call today from Aesthetic Medical International are Dr. Pengwu Zhou, Chairman and Chief Executive Officer; Mr. Toby Wu, Chief Financial Officer; and Mr. Derrick Shi, Investor Relations Associate Director.

Dr. Zhou will review the business operations and the company highlights, followed by Mr. Toby Wu, who will introduce the company's financial performance. They will all be available to answer your questions during the Q&A session that follows.

Before we get started, I'd like to remind you that some of the information discussed will include forward-looking statements regarding future events and our future financial performance. These include statements about our future expectations, financial projections and our plans and prospects. Actual results may differ materially from those set forth in such statements. For discussion of these risks and uncertainties, you should review the company's filings with the SEC, which includes today's press release. You should not rely on our forward-looking statements as predictions of future events.

All forward-looking statements that we make on this call are based on assumptions and beliefs as of today, and we undertake no obligation to update them, except as required by applicable law.

Our discussion today will include non-IFRS financial measures, including EBITDA, adjusted loss and adjusted EBITDA. You should not consider EBITDA, adjusted EBITDA or adjusted loss as a substitute for or superior to net income prepared in accordance with IFRS.

Furthermore, because of non-IFRS, measures are

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.